Cartesian Therapeutics (RNAC) Q1 2025 Earnings

Mar 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-10.5
-6.82
-3.14
0.54

Details

Expected EPS
-0.83
Actual EPS
-0.590508
Surprise EPS
0.24
Surprise Percent
+28.85%

Description

⁨Cartesian Therapeutics⁩ (⁦RNAC⁩) has reported earnings of ⁦-0.590508⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts